Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome

By Nissinen R   Paimela L   Julkunen H   Tienari PJ   Leirisalo-Repo M   Palosuo T   Vaarala O  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 6, 2003-11 ,pp. : 337-342

Informa Healthcare

Access to resources Recommend Favorite

Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism

By Tamai M   Kawakami A   Iwamoto N   Arima K   Aoyagi K   Eguchi K  

Scandinavian Journal of Rheumatology, Vol. 39, Iss. 4, 2010-08 ,pp. : 287-291

Informa Healthcare

Access to resources Recommend Favorite

CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy

By Young-Min Steven   Vaidya Bijay  

Clinical Rheumatology, Vol. 23, Iss. 6, 2004-12 ,pp. : 568-569

Springer Publishing Company

Access to resources Recommend Favorite

Conformation-dependent GAD65 autoantibodies in diabetes

By Luo D.   Gilliam L.   Greenbaum C.   Bekris L.   Hampe C.   Daniels T.   Richter W.   Marcovina S.   Rolandsson O.   Landin-Olsson M.   Kockum I.   Lernmark Å.  

Diabetologia, Vol. 47, Iss. 9, 2004-09 ,pp. : 1581-1591

Springer Publishing Company

Access to resources Recommend Favorite

Acute onset of rheumatoid arthritis associated with administration of a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with diabetes mellitus

By Sasaki Takashi  

Diabetology International, Vol. 1, Iss. 2, 2010-12 ,pp. : 90-92

Springer Publishing Company

Access to resources Recommend Favorite